MedPath
TGA Approval

Spironolactone Tablets USP 25mg (400797)

400797

Spironolactone Tablets USP 25mg

Alphapharm Pty Ltd

December 8, 2022

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

spironolactone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.